Microwave and conventional synthesis of ester based dicationic pyridinium ionic liquids carrying hydrazone linkage: DNA binding, anticancer and docking studies

被引:25
作者
Al-Sodies, Salsabeel A. [1 ]
Aouad, Mohamed Reda [1 ,2 ]
Ihmaid, Saleh [3 ]
Aljuhani, Ateyatallah [1 ]
Messali, Mouslim [1 ]
Ali, Imran [1 ,4 ]
Rezki, Nadjet [1 ,2 ]
机构
[1] Taibah Univ, Fac Sci, Dept Chem, Al Madinah Al Munawarah 30002, Saudi Arabia
[2] Univ Sci & Technol Mohamed Boudiaf, Fac Sci, Dept Chem, Lab Chim & Electrochim Complexes Metall LCECM UST, POB 1505, El Mnouar 31000, Oran, Algeria
[3] Taibah Univ, Pharm Coll, Pharmacognosy & Pharmaceut Chem Dept, Al Madinah Al Munawarah 30002, Saudi Arabia
[4] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India
关键词
Hydrazones; Dicationic pyridinium ionic liquids; Anticancer; DNA binding; Modeling; BIOLOGICAL-ACTIVITIES; ASSISTED SYNTHESIS; GLUTAMIC-ACID; IN-SILICO; DESIGN; COMPLEXES; DERIVATIVES; THALIDOMIDE; COPPER(II); TOXICITY;
D O I
10.1016/j.molstruc.2020.127756
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Novel task dicationic ionic liquids (Ts-DilLs) 6-29 were designed and synthesized, under both conventional and microwave conditions; through molecular hybridization of the appropriate bispyridines having a hydrazone linkage as spacer with some alkyl functionalized esters forming the counter cations. Beside the synthesized halogenated DilLs 6-11, fluorinated metal anions were introduced via metathesis reaction in order to create new dipyridinium ionic liquid-hydrazone hybrids 12-29. All newly synthesized DilLs were fully characterized using different spectroscopic tools such as H-1, C-13, F-19, P-31, B-11 NMR and Mass experiment. The DNA binding, anticancer and docking studies of the synthesized ionic liquids were also carried out. The DNA binding constants ranged from 4.5 x 10(4) to 7.2 x 10(4) M-1, indicating good DNA binding tendencies. The most active ionic liquids were 28 and 29 with 99.99 and 99.86% anticancer activities, respectively. The docking studies indicated DNA binding in the outer grooves of DNA. The reported ionic liquids may be used as future anticancer drugs. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:14
相关论文
共 44 条
  • [1] Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study
    Abdelgawad, Mohamed A.
    Labib, Madlen B.
    Abdel-Latif, Mahmoud
    [J]. BIOORGANIC CHEMISTRY, 2017, 74 : 212 - 220
  • [2] A Profile of the In Vitro Anti-Tumor Activity and In Silico ADME Predictions of Novel Benzothiazole Amide-Functionalized Imidazolium Ionic Liquids
    Al-blewi, Fawzia
    Rezki, Nadjet
    Naqvi, Arshi
    Uddin, Husna Qutb
    Al-Sodies, Salsabeel
    Messali, Mouslim
    Aouad, Mohamed Reda
    Bardaweel, Sanaa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
  • [3] Microwave-Assisted Synthesis of Some Potential Bioactive Imidazolium-Based Room-Temperature Ionic Liquids
    Albalawi, Ahmed H.
    El-Sayed, Wael S.
    Aljuhani, Ateyatallah
    Almutairi, Saud M.
    Rezki, Nadjet
    Aouad, Mohamed R.
    Messali, Mouslim
    [J]. MOLECULES, 2018, 23 (07):
  • [4] Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
    Ali, I.
    [J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 131 - 134
  • [5] Enantioselective toxicity and carcinogenesis
    Ali, Imran
    Aboul-Enein, Hassan Y.
    Ghanem, Ashraf
    [J]. CURRENT PHARMACEUTICAL ANALYSIS, 2005, 1 (01) : 109 - 125
  • [6] Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
    Ali, Imran
    Lone, Mohammad Nadeem
    Al-Othman, Zeid A.
    Al-Warthan, Abdulrahman
    Sanagi, Mohd Marsin
    [J]. CURRENT DRUG TARGETS, 2015, 16 (07) : 711 - 734
  • [7] Anticancer metallodrugs of glutamic acid sulphonamides: in silico, DNA binding, hemolysis and anticancer studies
    Ali, Imran
    Wani, Waseem A.
    Saleem, Kishwar
    Hsieh, Ming-Fa
    [J]. RSC ADVANCES, 2014, 4 (56): : 29629 - 29641
  • [8] Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
    Ali, Imran
    Wani, Waseem A.
    Saleem, Kishwar
    Haque, Ashanul
    [J]. CURRENT DRUG THERAPY, 2012, 7 (01) : 13 - 23
  • [9] Design and synthesis of thalidomide based dithiocarbamate Cu(II), Ni(II) and Ru(III) complexes as anticancer agents
    Ali, Imran
    Wani, Waseem A.
    Saleem, Kishwar
    Hseih, Ming-Fa
    [J]. POLYHEDRON, 2013, 56 : 134 - 143
  • [10] Curcumin-I Knoevenagel's condensates and their Schiff's bases as anticancer agents: Synthesis, pharmacological and simulation studies
    Ali, Imran
    Haque, Ashanul
    Saleem, Kishwar
    Hsieh, Ming Fa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (13) : 3808 - 3820